Resumen de Estudio del coste-beneficio de un programa de seguimiento a pacientes con riesgo cardiovascular
Otón Bellver-Monzó, Saray Mena Pastor, Victoria Villagrasa Sebastián, Laura Vilanova Amat
- español
El farmacéutico tiene que demostrar que es capaz de realizar unso servicios de calidad y su eficiencia antes de poder exigir la financiación de estos servicios. Este estudio es para analizar los costes derivados de la prestación de seguimiento para pacientes con enfermedad cardiovascular.
- English
The pharmacist needs to demonstrate that he is capable of carrying out and implementing quality services as well as his efficiency before being able to request that these services are financed.
The general aim of this study is to analyse the costs derived from offering a follow-up service for patients with cardiovascular disease and to evaluate its possible efficiency
